gefitinib has been researched along with docetaxel in 3 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (docetaxel) | Trials (docetaxel) | Recent Studies (post-2010) (docetaxel) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 101 | 0 | 33 |
Protein | Taxonomy | gefitinib (IC50) | docetaxel (IC50) |
---|---|---|---|
Tubulin beta-4A chain | Homo sapiens (human) | 0.5 | |
Tubulin beta chain | Homo sapiens (human) | 0.5 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
Tubulin alpha-3C chain | Homo sapiens (human) | 0.5 | |
Substance-K receptor | Homo sapiens (human) | 1.563 | |
Tubulin alpha-1B chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-4A chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-4B chain | Homo sapiens (human) | 0.5 | |
Growth hormone-releasing hormone receptor | Homo sapiens (human) | 0.0001 | |
Tubulin beta-3 chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-2A chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-8 chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-3E chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-1A chain | Homo sapiens (human) | 0.5 | |
Tubulin alpha-1C chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-6 chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-2B chain | Homo sapiens (human) | 0.5 | |
Tubulin beta-1 chain | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
3 other study(ies) available for gefitinib and docetaxel
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |